Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Vaccine|October 11, 2021
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemicNatalia A Molodecky, Hamid Jafari, Rana M Safdar, et al.
Lancet (London, England)|October 29, 2010
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialRoland W Sutter, T Jacob John, Hemant Jain, et al.
The Journal of Infectious Diseases|October 16, 2014
Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern IndiaSunil Bahl, Concepción F Estívariz, Roland W Sutter, et al.
The Lancet. Infectious Diseases|November 11, 2011
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trialConcepción F Estívariz, Hamid Jafari, Roland W Sutter, et al.
Lancet (London, England)|September 22, 2015
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialRoland W Sutter, Sunil Bahl, Jagadish M Deshpande, et al.
Science (New York, N.Y.)|August 23, 2014
Polio eradication. Efficacy of inactivated poliovirus vaccine in IndiaHamid Jafari, Jagadish M Deshpande, Roland W Sutter, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Pageof 5